Julie Waras Brogren is a life science executive with over 25 years of experience, recently appointed CEO of Gedea Biotech. Her career spans C-level roles in finance and commerce at Ascelia Pharma and leadership positions at Novo Nordisk, focusing on orphan oncology, womens health, and global product launches. She is described as hard-working, commercially driven, and sharp.
She is passionate about bringing breakthrough innovations to market to help patients with unmet medical needs. Julie has completed the Advanced Board Programme at INSEAD, valuing the network of remarkable leaders, and serves on the board of the European Innovation Council Fund, supporting early-stage innovation and strengthening European entrepreneurship.
Julie is inspired by advancing healthcare innovation from development to market, a mission that has defined her career across big pharma and startups.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.